251 related articles for article (PubMed ID: 9412618)
1. Warfarin use among patients with atrial fibrillation.
Brass LM; Krumholz HM; Scinto JM; Radford M
Stroke; 1997 Dec; 28(12):2382-9. PubMed ID: 9412618
[TBL] [Abstract][Full Text] [Related]
2. Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation.
Brass LM; Krumholz HM; Scinto JD; Mathur D; Radford M
Arch Intern Med; 1998 Oct; 158(19):2093-100. PubMed ID: 9801175
[TBL] [Abstract][Full Text] [Related]
3. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
6. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
7. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy for stroke prevention among Medicare beneficiaries hospitalized in Alaska with atrial fibrillation.
Gordian ME; Mustin HD
Alaska Med; 1998; 40(4):79-84. PubMed ID: 10202404
[TBL] [Abstract][Full Text] [Related]
9. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
[TBL] [Abstract][Full Text] [Related]
10. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
[TBL] [Abstract][Full Text] [Related]
11. The use of warfarin in veterans with atrial fibrillation.
Bravata DM; Rosenbeck K; Kancir S; Brass LM
BMC Cardiovasc Disord; 2004 Oct; 4(1):18. PubMed ID: 15498102
[TBL] [Abstract][Full Text] [Related]
12. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
[TBL] [Abstract][Full Text] [Related]
13. Additional risk factors in atrial fibrillation patients not receiving warfarin.
Wensley S; Keir S; Caine S; Mac Mahon M
Age Ageing; 1999 Jul; 28(4):355-7. PubMed ID: 10459787
[TBL] [Abstract][Full Text] [Related]
14. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.
Gurwitz JH; Monette J; Rochon PA; Eckler MA; Avorn J
Arch Intern Med; 1997 May; 157(9):978-84. PubMed ID: 9140268
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
17. Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.
Steinberg BA; Greiner MA; Hammill BG; Curtis LH; Benjamin EJ; Heckbert SR; Piccini JP
Cardiovasc Ther; 2015 Aug; 33(4):177-83. PubMed ID: 25930214
[TBL] [Abstract][Full Text] [Related]
18. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.
Antani MR; Beyth RJ; Covinsky KE; Anderson PA; Miller DG; Cebul RD; Quinn LM; Landefeld CS
J Gen Intern Med; 1996 Dec; 11(12):713-20. PubMed ID: 9016417
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
Giugliano RP; Ruff CT; Rost NS; Silverman S; Wiviott SD; Lowe C; Deenadayalu N; Murphy SA; Grip LT; Betcher JM; Duggal A; Dave J; Shi M; Mercuri M; Antman EM; Braunwald E;
Stroke; 2014 Aug; 45(8):2372-8. PubMed ID: 24947287
[TBL] [Abstract][Full Text] [Related]
20. Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
Evans A; Perez I; Yu G; Kalra L
Stroke; 2001 Dec; 32(12):2828-32. PubMed ID: 11739981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
